<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02507609</url>
  </required_header>
  <id_info>
    <org_study_id>KUH1160087</org_study_id>
    <nct_id>NCT02507609</nct_id>
  </id_info>
  <brief_title>Deep Neuromuscular Block on Cytokines Release and Postoperative Delirium</brief_title>
  <official_title>The Effect of Deep Neuromuscular Block on Cytokines Release and Postoperative Delirium of Elderly Patients Undergoing Total Hip Arthroplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Konkuk University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Konkuk University Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to determine the relationship between the degree of neuromuscular
      block, the release of cytokines and clinical outcomes in elderly patients undergoing
      orthopedic surgery. Investigators hypothesize that deep neuromuscular blockade decreases the
      release of cytokine and the incidence of postoperative delirium in elderly patients
      undergoing orthopedic surgery, compared with moderate neuromuscular blockade.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      -  Study design

           - This is a prospective, randomized, single blinded study.

        -  Measurement values

             -  Neuromuscular monitoring by post-tetanic count (PTC) during operation

             -  Regional cerebral oxygen saturation monitoring

             -  Mean systemic blood pressure (MBP), heart rate (HR)

             -  Cardiac index (CI), using non-invasive cardiac output monitor

             -  IL-1ß, IL-6, TNF-α, IL-10 and CRP

             -  Arterial blood gas analysis (ABGA)

             -  Laboratory values [Hemoglobin, Hematocrit, serum albumin, creatinine, CPK, LDH]

             -  Postoperative pain, using visual analogue scale (VAS)

             -  Postoperative nausea and vomiting (PONV)

             -  Total infused amounts of drugs

             -  Total anesthesia duration, intubation duration and operation duration

             -  Intubation duration, operation duration

             -  Incidence of postoperative intensive care unit (ICU) admission

             -  Total ICU staying duration, if patients admit to ICU

             -  Preoperative and postoperative left ventricular ejection fraction change

             -  Incidence of hypotension (mean blood pressure lesser than 60 mmHg)

             -  Incidence of postoperative delirium using confusion assessment method (CAM)
                intensive care unit (ICU)

             -  Total amount of blood products transfusion (paced red blood cells, fresh frozen
                plasma, platelet concentration, cryoprecipitate)

             -  Total amount of crystalloids and colloids infusion

             -  Total amount urine output
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2015</start_date>
  <completion_date type="Anticipated">July 2017</completion_date>
  <primary_completion_date type="Anticipated">July 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Interleukin 6</measure>
    <time_frame>postoperative 4 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>postoperative delirium</measure>
    <time_frame>up to postoperative day 7</time_frame>
    <description>The incidence of postoperative delirium will be assessed by using confusion assessment method (CAM)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">82</enrollment>
  <condition>Hip Fractures</condition>
  <arm_group>
    <arm_group_label>M group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>moderate neuromuscular blockade group by intermittent injection of rocuronium bromide</description>
  </arm_group>
  <arm_group>
    <arm_group_label>D group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>deep neuromuscular blockade group by continuous infusion of rocuronium bromide</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Moderate neuromuscular blockade</intervention_name>
    <description>TOF count is maintained to 1 to 2 by intermittent intravenous injection of rocuronium bromide 5 mg during operation</description>
    <arm_group_label>M group</arm_group_label>
    <other_name>Esmeron</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Deep neuromuscular blockade</intervention_name>
    <description>PTC is maintained to 1 to 2 degree by continuous infusion of rocuronium bromide intravenous route</description>
    <arm_group_label>D group</arm_group_label>
    <other_name>Esmeron</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All adult (more than 50 years old) patients scheduled for total hip arthroplasty and
             total knee arthroplasty who have signed the written informed consent.

        Exclusion Criteria:

          -  Inability to give informed consent

          -  Preexisting cognitive dysfunction or delirium

          -  Known allergy to rocuronium sugammadex

          -  Underlying liver dysfunction (AST and ALT more than 100 IU/l)

          -  Underlying kidney dysfunction (Serum Creatinine more than 1.5 mg/dl)

          -  Underlying neuromuscular disease

          -  Patients taking any medication with potential interference with neuromuscular
             transmission
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Seong-Hyop Kim, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Konkuk University Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Seong_Hyop Kim, M.D</last_name>
    <phone>82-2-2030-5454</phone>
    <email>yshkim75@daum.net</email>
  </overall_contact>
  <location>
    <facility>
      <name>Konkuk University Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>143-729</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Seoung-Hyop Kim, M.D,Ph.D</last_name>
      <phone>82-2-2030-5454</phone>
      <email>yshkim@daum.net</email>
    </contact>
    <investigator>
      <last_name>Seong-Hyop Kim, M.D,Ph.D</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>July 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 21, 2015</study_first_submitted>
  <study_first_submitted_qc>July 23, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 24, 2015</study_first_posted>
  <last_update_submitted>July 24, 2015</last_update_submitted>
  <last_update_submitted_qc>July 24, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 27, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Konkuk University Medical Center</investigator_affiliation>
    <investigator_full_name>Seong-Hyop Kim</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Delirium</mesh_term>
    <mesh_term>Hip Fractures</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rocuronium</mesh_term>
    <mesh_term>Bromides</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

